News | Stethoscopes | November 15, 2016

Pilot Study Results Support Efficacy of eMurmur Computer-Aided Auscultation Platform

Software platform demonstrates high sensitivity and specificity in differentiating innocent versus pathologic pediatric heart murmurs

CSD Labs, eMurmur computer-aided auscultation software platform, pilot study, heart murmurs in children

November 15, 2016 — Computational Signal Detection (CSD) Laboratories LLC announced the publication of data in support of the clinical utility of its eMurmur computer-aided auscultation (CAA) platform for early and ongoing heart-health screening of children.

According to the company, up to 90 percent of children will have a heart murmur at some point during their infancy or childhood. However, the majority of these heart murmurs detected in children will be clinically insignificant.

In this pilot study of 106 children at Children’s Hospital of Eastern Ontario, eMurmur differentiated pathologic from innocent heart murmurs with high sensitivity (87 percent) and specificity (100 percent), a positive predictive value of 100 percent, a negative predictive value of 90 percent, and high accuracy (94 percent) when compared with echocardiography as the gold standard for diagnosing murmurs.

CSD Labs has also clinically validated eMurmur as a tool for early and ongoing heart-health screening of teens, adults and elderly persons.

eMurmur is a software platform for the objective detection of heart murmurs that analyzes and classifies heart sounds acquired via an electronic stethoscope. The platform is comprised of an app that runs on a mobile device and is powered by SADIE, a Machine Intelligence Signal Analysis/Diagnosis Engine. Via Bluetooth or audio cable, the app pairs with any commercially available electronic stethoscope or other appropriate recording device, and receives and sends the acquired heart sounds to the HIPAA-compliant server for analysis. After a few seconds, the results are displayed to the healthcare professional on his/her mobile device where he/she can review, compare, consult or add his/her own findings in an efficient and standardized way.

CSD LABS CEO and Founder Andreas Schriefl, Ph.D., said eMurmur’s web portal offers medical professionals the capacity to retrieve a PDF report containing all results, and enables integration into electronic patient files and hospital information systems. Other benefits include e-consultation via the web portal (i.e., remote case reviewing by medical experts); and heart sound-monitoring by comparing current with previous auscultation data, including recordings and all findings.

For more information: www.csdlabs.com

Related Content

U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
Overlay Init